Aims: Studies have shown that all patients with oestrogen receptor positive (ER+) breast cancers treated by breast conservation surgery (BCS) benefit frown postoperative breast radiotherapy and tamoxifen because of an increased probability of survival. The aim of this study was to determine whether ...
Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer Bone mineral density was minimally increased in lumbar spine and femoralneck after 12 mo treatment with tamoxifen ( p =0.79 and 0.55, respectively). No ... J Zidan,Z Keidar,W Bash...
The general guidelines to management of breast cancer may not apply to the smallest of these tumors, as their metastatic potential may be smaller than larger tumors. Tumors < 5 mm (T1a) carry an excellent prognosis, despite a variety of treatment approaches. However, some patients' cancer ...
[9]Kvernby S, Flejmer AM, Dasu A, et al. T1 and T2 mapping for early detection of treatment-related myocardial changes in breast cancer patients[J]. J Magn Reson Imaging, 2022, 55(2): 620-622. DOI: 10.1002/...
This research highlights the potential usage of IL-37b gene/protein therapy in the future treatment of breast cancer in the clinic and provides insights for further research in this field. Acknowledgements This work was supported by the National Basic Research Pro- gram of China (2013CB966904, ...
Importance Adjuvant chemotherapy remains the only recommended treatment for patients with triple-negative breast cancer (TNBC). However, the existing evidence is not enough to recommend adjuvant therapies to patients with T1 N0 M0 TNBC. Objective To evaluate the association of different adjuvant therapies...
Breast-conserving surgery (BCS) plus radiotherapy and mastectomy exhibit highly comparable prognoses for early-stage breast cancer; however, the safety of BCS for T1-2N3M0 breast cancer remains unclear. This study compared long-term survival for BCS versus (vs.) modified radical mastectomy (MRM) ...
Fontana D, Bellina M, Galietti F, et al: Intravesical Bacillus Calmette-Guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21/waf1 during treatment of superficial bladder cancer. J Urol 1999; 162: 225-230. Lipponen PK, Aaltomaa S, Eskelinen M, et al: Expression of p21(waf...
- 《European Journal of Cancer》 被引量: 119发表: 1993年 Prognostic significance of serum prolactin levels in advanced breast cancer. Serum prolactin concentrations were measured in 135 postmenopausal patients with advanced breast cancer prior to their treatment with one of 3 endocrine th... M,...
[9] Harbeck N. Emerging strategies in neoadjuvant treatment of patients with her2-positive early breast cancer[J]. Breast, 2019, 48 Suppl 1: S97-S102. [10]Mano MS, Oliveira LJC, Hanna SA. Integrating adjuvant radia...